Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2026-03-04 @ 6:44 AM
Study NCT ID:
NCT00887159
Status:
COMPLETED
Last Update Posted:
2021-01-05
First Post:
2009-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07-16
Start Date Type:
ACTUAL
Primary Completion Date:
2016-11-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-11-15
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-22
First Submit QC Date:
None
Study First Post Date:
2009-04-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-07-01
Results First Submit QC Date:
None
Results First Post Date:
2015-07-29
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-10
Last Update Post Date:
2021-01-05
Last Update Post Date Type:
ACTUAL